Bionomics R&D Tax Incentive for FY2012
January 14, 2013 18:20 ET
|
Bionomics Limited
ADELAIDE, South Australia, Jan. 14, 2013 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) has lodged its FY2012 tax return and registered with AusIndustry (on behalf of Innovation...
Ironwood Begins Phase I Trial of Investigational IW-2143 Anxiety Drug in US
December 21, 2012 06:30 ET
|
Bionomics Limited
ADELAIDE, Australia, Dec. 21, 2012 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) has been advised by its licensee Ironwood Pharmaceuticals Inc (Nasdaq:IRWD) that, following the...
IND Submission to FDA for IW-2143 (BNC210) Anti-Anxiety Drug Candidate
November 08, 2012 09:44 ET
|
Bionomics Limited
Bionomics' licensee Ironwood Pharmaceuticals has submitted an Investigational New Drug application to the US Food & Drug Administration (FDA)
IND is a precursor to proceeding with...
Alpha 7 Program to be Showcased at Neuroscience 2012
October 16, 2012 06:30 ET
|
Bionomics Limited
Targets Alzheimer's disease and confirms Bionomics' focus on well differentiated drug candidates targeting large markets
Competitive advantages combine potency and selectivity with rapid...
Bionomics Acquires US-Based Cancer Stem Cell Company Eclipse Therapeutics
September 17, 2012 06:30 ET
|
Bionomics Limited
Teleconference
11am AEST, 10.30 Adelaide time, today
To listen online copy the following link to your web browser:
brrmedia.com/event/103835/?popup=true
To ask questions telephone and cite...
Bionomics Key Additions to Executive Team
September 11, 2012 21:25 ET
|
Bionomics Limited
Appointment of Dr José Iglesias as Chief Medical Officer
Dr Jeremy Simpson as Vice President of Clinical Development
Dr Sue O'Connor as Vice President of Neuroscience...